Predictive performance of breast cancer index (BCI) and clinical treatment score post-5 years (CTS5) in the IDEAL study.

被引:0
|
作者
Liefers, Gerrit-Jan
Noordhoek, Iris
Putter, Hein
Wong, Jenna
Siuliukina, Natalia
Zhang, Yi
Kranenbarg, Elma Meershoek-Klein
Duijm-de Carpentier, Marjolijn
Van De Velde, Cornelis J. H.
Schnabel, Catherine A.
Treuner, Kai
机构
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Leiden Univ, Dept Med Stat, Med Ctr, Leiden, Netherlands
[3] Biotheranost Holog Co, San Diego, CA USA
[4] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
545
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index
    Janghee Lee
    Chihwan Cha
    Sung Gwe Ahn
    Dooreh Kim
    Soeun Park
    Soong June Bae
    Jeeye Kim
    Hyung Seok Park
    Seho Park
    Seung Il Kim
    Byeong-Woo Park
    Joon Jeong
    Scientific Reports, 10
  • [2] Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index
    Lee, Janghee
    Cha, Chihwan
    Ahn, Sung Gwe
    Kim, Dooreh
    Park, Soeun
    Bae, Soong June
    Kim, Jeeye
    Park, Hyung Seok
    Park, Seho
    Kim, Seung Il
    Park, Byeong-Woo
    Jeong, Joon
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [3] Clinical relevance of clinical treatment score post-5 years (CTS5) in HR-positive, HER2-positive breast cancer
    Bae, Soong June
    Moon, Sohyun
    Kook, Yoonwon
    Baek, Seung Ho
    Lee, Minji
    Kim, Jee Hung
    Ahn, Sung Gwe
    Jeong, Joon
    NPJ BREAST CANCER, 2025, 11 (01)
  • [4] Author Correction: Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index
    Janghee Lee
    Chihwan Cha
    Sung Gwe Ahn
    Dooreh Kim
    Soeun Park
    Soong June Bae
    Jeeye Kim
    Hyung Seok Park
    Seho Park
    Seung Il Kim
    Byeong‑Woo Park
    Joon Jeong
    Scientific Reports, 11
  • [5] Clinical Treatment Score Post-5 Years (CTS5) and Late Recurrence Risk in Hormone Receptor-Positive, HER2-Positive Breast Cancer
    Chumsri, Saranya
    Pai, Tanmayi
    Ma, Yaohua
    Li, Zhuo
    Gil, Angelica
    Moreno-Aspitia, Alvaro
    Colon-Otero, Gerardo
    Pogue-Geile, Katherine L.
    Rasgoti, Priya
    Paik, Soonmyung
    Perez, Edith A.
    Thompson, E. Aubrey
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (07): : 463 - 468
  • [6] Clinical treatment score post-5 years (CTS5) as a tool for risk estimation of late recurrence in Thai patients with estrogen receptor positive, early breast cancer: A validation study
    Patanayindee, P.
    Dejthevaporn, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S438 - S438
  • [7] Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index (vol 10, 16850, 2020)
    Lee, Janghee
    Cha, Chihwan
    Ahn, Sung Gwe
    Kim, Dooreh
    Park, Soeun
    Bae, Soong June
    Kim, Jeeye
    Park, Hyung Seok
    Park, Seho
    Kim, Seung Il
    Park, Byeong-Woo
    Jeong, Joon
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Clinical treatment score post-5 years (CTS5) and the prediction of survival benefit from extended endocrine therapy for breast cancer patients under and over 50 years of age
    Ahn, Jee Hyun
    Park, Jung Min
    Choi, Soon Bo
    Go, Jieon
    Kim, Jee Ye
    Park, Hyung Seok
    Kim, Seung Il
    Park, Byeong-Woo
    Park, Seho
    CANCER RESEARCH, 2022, 82 (04)
  • [9] Clinical treatment score Post-5 Years (CTS5) predicts the benefit of postmastectomy radiotherapy in patients with T1-2N1 luminal breast cancer
    Liu, Ke
    Li, Guan-Qiao
    Li, Si-Qi
    Chen, Xue-Qin
    Wu, San-Gang
    BREAST, 2025, 79
  • [10] Clinical utility of the clinical treatment score at 5 years (CTS5) in a single tertiary cancer centre
    Richman, Juliet
    Allen, Mark
    Snuggs, Nikki
    Sestak, Ivana
    Ring, Alistair
    Dowsett, Mitch
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 556 - 557